Similar articles

• [Current status of clinical knowledge, physiopathology, and treatment of Langerhans histiocytosis (histiocytosis X)].

  Geissmann F, Thomas C. Geissmann F, et al. Arch Pediatr. 1999;6 Suppl 2:414s-416s. doi: 10.1016/s0929-693x(99)80486-2. Arch Pediatr. 1999. PMID: 10370554 Review. French. No abstract available.
• Langerhans cell histiocytosis of the maxillae in a child treated only with chemotherapy: a case report.

  Cazzolla AP, Troiano G, Zhurakivska K, Maiorano E, Favia G, Lacaita MG, Marzo G, Dicuonzo F, Andresciani S, Muzio LL. Cazzolla AP, et al. J Med Case Rep. 2017 May 9;11(1):130. doi: 10.1186/s13256-017-1286-3. J Med Case Rep. 2017. PMID: 28482919 Free PMC article.
• Allogeneic bone marrow transplantation in a patient with chemotherapy-resistant progressive histiocytosis X.

  Dehner LP. Dehner LP. N Engl J Med. 1987 Sep 17;317(12):773-4. doi: 10.1056/NEJM198709173171221. N Engl J Med. 1987. PMID: 3306383 No abstract available.
• [Cerebellar syndromes in Langerhans' cell histiocytosis].

  Bös M, Grothe C, Urbach H, Schröder R. Bös M, et al. Nervenarzt. 2007 Apr;78(4):437-40. doi: 10.1007/s00115-006-2238-0. Nervenarzt. 2007. PMID: 17235421 German.
• Clinical Characteristics and Treatment of Langerhans Cell Histiocytosis.

  Monsereenusorn C, Rodriguez-Galindo C. Monsereenusorn C, et al. Hematol Oncol Clin North Am. 2015 Oct;29(5):853-73. doi: 10.1016/j.hoc.2015.06.005. Epub 2015 Aug 18. Hematol Oncol Clin North Am. 2015. PMID: 26461147 Review.